1. The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial. Issue 7 (July 2022) Authors: Tiddens, Harm A W M; Chen, Yuxin; Andrinopoulou, Eleni-Rosalina; Davis, Stephanie D; Rosenfeld, Margaret; Ratjen, Felix; Kronmal, Richard A; Hinckley Stukovsky, Karen D; Dasiewicz, Alison; Stick, Stephen Michael; Andrinopoulou, Eleni-Rosalina; Anthony, Margaret M.; Au, Jacky; Belessis, Yvonne; Bo... Journal: Lancet Issue: Volume 10:Issue 7(2022) Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term effect of CFTR modulator therapy on airway nitric oxide. Issue 1 (9th January 2020) Authors: Grasemann, Hartmut; Klingel, Michelle; Avolio, Julie; Prentice, Carley; Gonska, Tanja; Tullis, Elizabeth; Ratjen, Felix Journal: European respiratory journal Issue: Volume 55:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9 (September 2019) Authors: Ratjen, Felix; Davis, Stephanie D; Stanojevic, Sanja; Kronmal, Richard A; Hinckley Stukovsky, Karen D; Jorgensen, Neal; Rosenfeld, Margaret; Kerby, Gwen; Kopecky, Carol; Anthony, Meg; Mogayzel, Peter; Walker, Doug; Zeglin, Britany; Hoover, Wynton; Hathorne, Heather; Slaten, Katie; Dorkin, Henry (... Journal: Lancet Issue: Volume 7:Issue 9(2019) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗